Amrita Krishnamurthy, MD
Cardiovascular Disease (Cardiology) · Dublin
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 12
Offices
12 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: San Ramon Regional Medical Center · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Krishnamurthy’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- San Ramon Regional Medical CenterSan Ramon, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for San Ramon Regional Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 507 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.44 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.1 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 87 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 195 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 284 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 63 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,118 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,515 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.49) · 2,618 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.62 (1.26 to 5.98) · 588 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.14) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.34 (0.72 to 3.97) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.12 (0.84 to 15.4) · 258 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.25 to 7.91) · 225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.02 (0.52 to 3.52) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.29) · 2,110 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 73 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.553 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.104 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 84 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 186 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 39.6 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -10.3 · 227 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.2 · 305 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 314 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.3) · 86 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 256 cases | No different | Jan 2024 – Dec 2024 |
What patients said (642 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$165,245
Medicare paid this office $165,245 for 2,913 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $43,002 | $177 |
| Return visit (30+ min) | 232 | $37,260 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,576 | $16,679 | $7 |
| Critical care, first 30-74 minutes | 32 | $13,581 | $200 |
| New patient visit (45+ min) | 86 | $11,960 | $139 |
See all 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 243 | $43,002 | $177 |
| Return visit (30+ min) | 232 | $37,260 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,576 | $16,679 | $7 |
| Critical care, first 30-74 minutes | 32 | $13,581 | $200 |
| New patient visit (45+ min) | 86 | $11,960 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 708 | $9,720 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 150 | $8,877 | $58 |
| Long return visit (40+ min) | 31 | $5,850 | $167 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 191 | $3,904 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,923 | $162 |
| New patient visit (60+ min) | 12 | $2,540 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,401 | $74 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,253 | $84 |
| Insertion of needle into vein for collection of blood sample | 95 | $917 | $9 |
| Ultrasound of heart, follow-up | 15 | $385 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $251 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $211 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $209 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $140 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $106 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $58 | $3 |
Who their Medicare patients are
2,913 Original Medicare patients in 2024. Average age 76 · Under 65 8% · 85 and older 20% · Women 54% · Also on Medicaid 23% · Health risk score 2.19. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 56% · Heart failure 39% · Atrial fibrillation 39% · Diabetes 37% · Chronic kidney disease 34% · Depression 27% · Cancer 26% · COPD 24% · Stroke 20% · Dementia 17%.
The office billed $1,026,330, Medicare allowed $218,166 and paid $165,245; for 4,548 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,913 | 4,548 | 76 | 2.19 | $1,026,330 | $165,245 |
| 2023 | 1,086 | 1,549 | 76 | 2.32 | $828,655 | $132,427 |
| 2022 | 292 | 431 | 76 | 2.03 | $249,445 | $49,332 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $37,140 | $167 |
| Return visit (30+ min) | 186 | $28,099 | $108 |
| Critical care, first 30-74 minutes | 35 | $19,879 | $191 |
| New patient visit (45+ min) | 103 | $14,354 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 231 | $13,573 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $4,090 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,472 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,909 | $100 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 194 | $1,504 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 98 | $1,259 | $13 |
| Insertion of needle into vein for collection of blood sample | 63 | $605 | $8 |
| Ultrasound of heart, follow-up | 23 | $453 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $86 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $82 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $37 | $3 |
2022: 8 services
| Critical care, first 30-74 minutes | 33 | $12,069 | $198 |
| New patient visit (45+ min) | 67 | $10,213 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $6,766 | $183 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $5,540 | $61 |
| Return visit (30+ min) | 34 | $4,345 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $4,314 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,151 | $64 |
| Insertion of needle into vein for collection of blood sample | 13 | $41 | $3 |
Medicaid work
$19,111 in 2024
Medicaid paid $19,111 for 1,832 billed services this clinician did in 2024, up to 152 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,394 | $8,593 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 85 | $4,469 |
| Return visit (30+ min) | 94 | $4,174 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 234 | $1,874 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 25 | $0 |
| 2024 | 1,832 | 5 | 152 | $19,111 |
| 2023 | 282 | 3 | 33 | $10,732 |
| 2022 | 18 | 1 | 18 | $575 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 127 | $7,520 |
| Return visit (30+ min) | 57 | $2,677 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 98 | $534 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 18 | $575 |
Drugs they prescribed that Part D paid
$242,693
Pharmacies billed $242,693 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,357) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,125 generic and 232 brand-name prescriptions · $242,693 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 93 | $108,354 | $1,165 |
| Repatha Sureclick | 28 | $31,651 | $1,130 |
| Xarelto | 27 | $30,299 | $1,122 |
| Brilinta | 20 | $13,413 | $671 |
| Entresto | 11 | $11,576 | $1,052 |
See all 24 drugs
| Eliquis | 93 | $108,354 | $1,165 |
| Repatha Sureclick | 28 | $31,651 | $1,130 |
| Xarelto | 27 | $30,299 | $1,122 |
| Brilinta | 20 | $13,413 | $671 |
| Entresto | 11 | $11,576 | $1,052 |
| Farxiga | 13 | $8,344 | $642 |
| Jardiance | 14 | $8,086 | $578 |
| Rosuvastatin | 183 | $3,284 | $18 |
| Metoprolol | 171 | $2,274 | $13 |
| Atorvastatin | 101 | $1,079 | $11 |
| Ezetimibe | 41 | $940 | $23 |
| Losartan | 88 | $752 | $9 |
| Amlodipine Besylate | 84 | $581 | $7 |
| Diltiazem 24hr Er (Cd) | 16 | $563 | $35 |
| Carvedilol | 54 | $353 | $7 |
| Lisinopril | 51 | $267 | $5 |
| Furosemide | 46 | $266 | $6 |
| Isosorbide Mononitrate Er | 17 | $232 | $14 |
| Hydrochlorothiazide | 36 | $229 | $6 |
| Spironolactone | 34 | $212 | $6 |
| Clopidogrel | 18 | $198 | $11 |
| Torsemide | 11 | $155 | $14 |
| Propranolol | 18 | $130 | $7 |
| Atenolol | 12 | $22 | $2 |
Year by year
| 2024 | 1,357 | 284 | 0% (0) | 17% | $242,693 |
| 2023 | 1,042 | 227 | 0% (0) | 13% | $175,457 |
| 2022 | 303 | 83 | 0% (0) | 12% | $33,898 |
| 2021 | 164 | 25 | 0% (0) | 12% | $12,437 |
| 2020 | 141 | 28 | 0% (0) | 25% | $13,390 |
| 2019 | 20 | None | 0% (0) | None | $1,735 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 60 | $71,786 | $1,196 |
| Farxiga | 22 | $21,326 | $969 |
| Entresto | 11 | $15,515 | $1,410 |
| Metoprolol | 149 | $3,496 | $23 |
| Rosuvastatin | 113 | $1,950 | $17 |
| Ezetimibe | 39 | $1,470 | $38 |
| Losartan | 74 | $1,381 | $19 |
| Atorvastatin | 85 | $1,322 | $16 |
| Isosorbide Mononitrate Er | 28 | $734 | $26 |
| Carvedilol | 41 | $656 | $16 |
| Amlodipine Besylate | 56 | $541 | $10 |
| Nifedipine Er | 13 | $538 | $41 |
| Furosemide | 35 | $369 | $11 |
| Clopidogrel | 25 | $367 | $15 |
| Torsemide | 16 | $344 | $21 |
| Propranolol | 16 | $295 | $18 |
| Spironolactone | 25 | $293 | $12 |
| Nitroglycerin | 11 | $236 | $21 |
| Lisinopril | 39 | $158 | $4 |
| Hydrochlorothiazide | 26 | $143 | $5 |
2022: 10 drugs
| Rosuvastatin | 33 | $1,196 | $36 |
| Atorvastatin | 46 | $848 | $18 |
| Metoprolol | 23 | $559 | $24 |
| Ezetimibe | 23 | $508 | $22 |
| Carvedilol | 13 | $472 | $36 |
| Spironolactone | 11 | $174 | $16 |
| Lisinopril | 14 | $168 | $12 |
| Losartan | 20 | $151 | $8 |
| Furosemide | 13 | $150 | $12 |
| Isosorbide Mononitrate Er | 12 | $95 | $8 |
2021: 4 drugs
| Carvedilol | 24 | $595 | $25 |
| Atorvastatin | 30 | $529 | $18 |
| Spironolactone | 12 | $163 | $14 |
| Losartan | 12 | $124 | $10 |
2020: 1 drug
| Isosorbide Mononitrate Er | 13 | $142 | $11 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2024 | 2 | 2 | None | $256 |
| 2023 | 2 | 2 | None | $199 |
| 2022 | 2 | 3 | None | $171 |
| 2021 | 2 | 6 | None | $168 |
| 2020 | 4 | 9 | None | $369 |
| 2019 | 5 | 9 | None | $266 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Leqvio | $26 | 1 payment
|
See the published payment
| Novartis Pharmaceuticals | Meals · 2025-09-30 | Leqvio | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $256
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $190 | 1 payment
|
| Amgen | None | $67 | 1 payment
|
2023: $199
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $177 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $22 | 1 payment
|
2022: $171
| Abbott Laboratories | Ensite Precision | $139 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $32 | 2 payments
|
2021: $168
| Medtronic | Azure | $90 | 3 payments
|
| Amgen | Repatha | $78 | 3 payments
|
2020: $369
| Medtronic Vascular | Micra | $157 | 5 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $150 | 1 payment
|
| Amgen | Repatha | $43 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $19 | 1 payment
|
2019: $266
| Medtronic Vascular | Azure | $104 | 3 payments
|
| Amgen | Corlanor | $75 | 3 payments
|
| Abbott Laboratories | Merlin Connectivity and Remote | $36 | 1 payment
|
| Boston Scientific | Zoom | $28 | 1 payment
|
| Novo Nordisk | Ozempic | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649674268
- Licence
- NY 298559
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-10-09
- NPI last updated
- 2025-04-29
- NPI record certified
- 2025-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1305 York Ave Fl 8, New York, NY, 10021